Voxelotor veelbelovend bij sikkelcelziekte

Delen via:
EHA 2019

Log hier in om volledige toegang te krijgen.

Login of Account maken

 

Bronnen:
Vichinsky E, Hoppe CC, Ataga KI, et al. Results from the randomized placebo-controlled phase 3 HOPE trial of voxelotor in adults and adolescents with sickle cell disease. 24th Congress of EHA, abstract S147.